MS
Michael Schmidt Guggenheim Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
44
Avg Return
Past Year
Past Year
63%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $20 |
5%
upside
| 1 | +1.7% |
0
%
| 16 Mar ‘26 1 month ago |
|
|
|
Buy
Reiterated
| $10 |
107%
upside
| 2 | +27% |
0
%
| 9 Mar ‘26 1 month ago |
|
|
|
Buy
Initiated
| $12 |
180%
upside
| 1 | -4% |
0
%
| 9 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $20 |
25%
downside
| 2 | +40% |
0
%
| 6 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $410 |
27%
upside
| 1 | +7.8% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $40 |
40%
upside
| 1 | -3.6% |
0
%
| 23 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $26 |
23%
downside
| 1 | +292% |
0
%
| 6 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $160 |
8%
upside
| 1 | +63% |
0
%
| 20 Jan ‘26 2 months ago |
|